Clarisse Audigier-Valette

机构：Université de Toulon, Hôpital d'Instruction des Armées Sainte-Anne, Centre Hospitalier Intercommunal Toulon-La Seyne-sur-Mer · ORCID：0000-0002-9518-9162

发表论文 311 篇 · 总被引 13465 次 · h-index 39

代表论文

• Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08–2015 ENERGY): a randomised, open-label, phase 3 study (2024 · The Lancet Respiratory Medicine · 被引 18)
• Clinical characteristics and management of long survivors in extensive stage small cell lung cancer (2025 · Lung Cancer · 被引 7)
• Next-generation multicenter studies: using artificial intelligence to automatically process unstructured health records of patients with lung cancer across multiple institutions (2025 · Annals of Oncology · 被引 5)
• MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial (2025 · Translational Oncology · 被引 5)
• Final 3-year results from the EVIDENS study, an observational study of nivolumab in non-small cell lung cancer (2025 · OncoImmunology · 被引 4)
• Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer (2025 · Journal of Nuclear Medicine · 被引 1)